Cargando…
Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
Autores principales: | Guillon, A., Hiemstra, P. S., Si-Tahar, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366461/ https://www.ncbi.nlm.nih.gov/pubmed/32681297 http://dx.doi.org/10.1007/s00134-020-06170-8 |
Ejemplares similares
-
Targeting TMPRSS2 in SARS-CoV-2 Infection
por: Baughn, Linda B., et al.
Publicado: (2020) -
Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview
por: Carter, Michael J., et al.
Publicado: (2020) -
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
por: Zhang, Haibo, et al.
Publicado: (2020) -
Compartmentalisation of immune responses in critical illness: does it matter?
por: Conway Morris, Andrew, et al.
Publicado: (2022) -
Pulmonary complications in liver disease
por: Bauer, Michael, et al.
Publicado: (2019)